Work at RxSight®

World Leader in Adjustable Lens Technology for Cataract Patients

At RxSight, we’re not just building breakthrough technology—we’re transforming what’s possible in vision care. As the team behind the world’s first and only adjustable intraocular lens, our mission is clear: To give patients the power to fine-tune their vision after cataract surgery. We’re a passionate, agile team driven by purpose. Innovation is our everyday, and collaboration is in our DNA. Here, diverse perspectives are valued, bold ideas are welcomed, and every role makes a real difference in people’s lives.

View Open Positions

Why Work at RxSight?

Supportive Work Environment

With most of our team onsite, we've built a culture where collaboration comes naturally and support is part of the everyday experience. Our core values of teamwork, respect, customer focus, and a strong sense of urgency shape how we work together and how we show up for one another. Whether solving challenges or celebrating wins, we operate with care, clarity, and a shared commitment to helping each other succeed.

Employee Recognition

We celebrate success and value employee recognition. We have developed our incredible Eye Inspire program to encourage peer-to-peer recognition of our employees throughout the year as well as our yearly Spectocular Award program which recognizes outstanding achievements by employees who are nominated by our management team. We've also recently introduced the 20/20 Teamwork Award to spotlight exceptional cross-functional collaboration, and our Spot Awards provide quick, meaningful recognition from managers to employees who go above and beyond.

Culture and Connection

From smoothie bars and food trucks to spirit weeks and our signature summer and winter events, we’re intentional about creating moments that bring people together. We believe culture is built not just through the work we do, but through the connections we make—and we make it a point to celebrate each other along the way. Our volunteer program, Eyes on Impact, is aimed at giving back to the communities we care about. Employees have the opportunity to sign up for one volunteer day a year to participate in community service or charitable activities.

89% Employee Approval Rate

In a 2024 survey, 89% of employees say they would recommend working at RxSight.​

Employee Benefits & Investment

We have designed our benefits offerings to support what matters most to our employees. We offer a comprehensive package of compensation and benefits to support your well-being, your family, and your future.

  • Medical, dental, and vision coverage
  • Company-paid life insurance policy
  • Company-paid short-term and long-term disability insurance
  • HSA/FSA and supplemental health plans
  • Employee assistance programs and confidential mental wellness benefits
  • 401(k) matching
  • RxSight stock options
  • Employee stock purchase plan
View Open Positions
LAL patients saw nearly as well without glasses (UCDVA) as control patients did with glasses (BCDVA).

The Light Adjustable Lens provides optimized vision for patient satisfaction.2

Light Adjustable Lens patients saw nearly as well without glasses (UCDVA) as control patients did with glasses (BCDVA).

Since the Light Adjustable Lens is a monofocal lens, there is low risk of dysphotopsias caused by splitting light, leading to potentially enhanced vision and patient satisfaction.

LAL patients are approximately two times more likely to achieve 20/20 vision or better without glasses at 6 months.

The Light Adjustable Lens offers LASIK-like accuracy in cataract surgery.2,3

92% of eyes (N = 391) achieved results within 0.50 D of target manifest refraction spherical equivalent (MRSE).

Patients are approximately two times more likely to achieve 20/20 vision or better without glasses at 6 months.

The study was a prospective, controlled, multicenter, 12-month study of 600 patients (ITT population) randomized to receive implantation with the RxSight LAL (N = 403) or a commercially available monofocal IOL (N = 197). Effectiveness analyses included 391 LAL patients and 193 control patients. Primary safety variables included best spectacle-corrected visual acuity (BSCVA) at 6 months and incidence of sight-threatening complications and adverse events. Primary effectiveness variables included percent reduction in manifest cylinder at 6 months, percent mean absolute reduction in MRSE at 6 months, and rotation of meridian of LAL at 6 months. Percent of eyes with an uncorrected visual acuity (UCVA) of 20/20 or better at six months post-operatively compared between the LAL treatment group and the monofocal control group was a secondary endpoint.

The Light Adjustable Lens corrects as low as 0.50 D of astigmatism, which is the lowest level approved to be treated.

The ability to treat 0.50 D of postoperative cylinder makes the Light Adjustable Lens the only IOL in the United States approved to correct this level of vision-altering astigmatism. Astigmatism of as little as 0.50 D can reduce visual acuity by one line, and the impact on dynamic, functional visual acuity and low-contrast acuity is even greater.1